Table 6.
Association between METS-IR and CAD severity
| Variables | Multi-vessel coronary artery disease | |||||
|---|---|---|---|---|---|---|
| OR (95% CI)a | P-value | OR (95% CI)b | P-value | OR (95% CI)c | P-value | |
| METS-IR | 1.166 (1.118–1.217) | < 0.001 | 1.180 (1.129–1.233) | < 0.001 | 1.160 (1.104–1.219) | < 0.001 |
| M1 | Reference | Reference | Reference | |||
| M2 | 1.307 (0.823–2.075) | 0.256 | 1.312 (0.818–2.104) | 0.259 | 1.151 (0.694–1.911) | 0.586 |
| M3 | 12.725 (5.591–28.965) | < 0.001 | 16.320 (6.983–38.142) | < 0.001 | 11.314 (4.521–28.314) | < 0.001 |
OR, odds ratios; CI, confidence interval; METS-IR, metabolic score for insulin resistance; M1: METS-IR < 38.405; M2: 38.405 ≤ METS-IR < 44.658; M3: 44.658 ≤ METS-IR
aModel 10: Unadjusted
bModel 11: Adjusted for age and sex
cModel 12: Adjusted for age, sex, DM, hypertension, HbA1c, UA, LAD, IVS, LVPW